0000899243-18-027381.txt : 20181024
0000899243-18-027381.hdr.sgml : 20181024
20181024170326
ACCESSION NUMBER: 0000899243-18-027381
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181018
FILED AS OF DATE: 20181024
DATE AS OF CHANGE: 20181024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chereau Frederic
CENTRAL INDEX KEY: 0001640592
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38707
FILM NUMBER: 181136980
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 3545 JOHN HOPKINS COURT, SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LogicBio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001664106
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 471514975
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 61(0)428-338-594
MAIL ADDRESS:
STREET 1: 700 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2018-10-18
2018-10-22
0
0001664106
LogicBio Therapeutics, Inc.
LOGC
0001640592
Chereau Frederic
C/O LOGICBIO THERAPEUTICS, INC.
610 MAIN ST., 3RD FLOOR
CAMBRIDGE
MA
02139
1
1
0
0
President, CEO
Employee Stock Option (right to buy)
10.00
2018-10-18
4
A
0
155000
0.00
A
2028-10-17
Common Stock
155000
155000
D
The option becomes exercisable in equal one forty-eighth installments from the vesting commencement date, October 18, 2018.
The Form 4, as originally filed, incorrectly reported the number of derivative securities acquired, the amount of underlying securities and the number of derivative securities beneficially owned. The Form 4, as amended by this Form 4/A, correctly reports such information.
/s/ Matthias Jaffe, as Attorney-in-Fact
2018-10-24